Photocure ASA
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Visonac that has completed Phase II study for the treatment of moderate to severe acne; and Cevira, which has completed Phase II study for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to license partners, pharmaceutical wholesalers, and hospitals. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. Show More...
-
Website http://www.photocure.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 50.20 NOK
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share NOK 0.83 -0.35 -2.25 -2.78 -1.16 -1.69 1.64 -1.61 -1.7 1.46 0.88 Dividends NOK 2.0 Payout Ratio % * Shares Mil 22.0 22.0 21.0 21.0 21.0 21.0 22.0 22.0 22.0 22.0 22.0 Book Value Per Share * NOK 21.92 19.06 17.98 12.75 12.98 10.15 10.86 10.7 8.39 7.63 7.91 Free Cash Flow Per Share * NOK 13.32 0.57 -3.21 -2.61 -1.04 -1.59 -2.3 -0.33 -1.43 0.010 Return on Assets % 3.73 -1.47 -10.17 -16.05 -8.63 -13.95 13.23 -12.64 -14.85 13.03 8.06 Financial Leverage (Average) 1.12 1.16 1.14 1.12 1.13 1.18 1.13 1.21 1.31 1.23 1.26 Return on Equity % 4.14 -1.67 -11.69 -18.16 -9.7 -16.07 15.29 -14.76 -18.61 16.54 10.51 Return on Invested Capital % 1.72 -3.26 -14.18 -19.65 -10.89 -16.39 14.51 -15.57 -19.21 15.31 7.03 Interest Coverage 4.95 -19.08 Current Ratio 7.88 5.56 6.42 6.5 7.07 6.01 7.02 4.36 2.93 4.83 4.66 Quick Ratio 7.54 5.39 6.15 5.95 6.44 5.48 6.32 3.77 2.49 4.3 4.24 Debt/Equity 0.03 0.04